PET imaging of cellular proliferation
Section snippets
Biologic and quantitative considerations
DNA synthesis is required for cell growth and proliferation [1]. Nucleotides of the four bases (cytosine, guanine, adenine, and thymidine) are required for DNA synthesis, and measurements of the rate of their incorporation into DNA yield the DNA synthetic rate. Of the four nucleosides, thymidine is the only one incorporated exclusively into DNA, and not RNA, and provides a measure of DNA synthesis independent of RNA synthesis [2]. Thymidine exogenous to the cell can be incorporated into DNA by
Clinical applications of cellular proliferation imaging
At this time, proliferation imaging is not used in routine clinical practice. A variety of pilot clinical studies have been conducted for [11C]-thymidine and more recently for the analogues, especially FLT. Studies in patients are reviewed, with an emphasis on feasibility, image interpretation and quantitative analysis, and likely future clinical applications.
Summary
PET cellular proliferation imaging has its roots in a long history of in vitro cellular proliferation studies to characterize cancer and in the understanding of the biology of thymidine incorporation into DNA gained from these studies. PET imaging represents the logical translation of the in vitro work to measure in vivo tumor proliferation. Preclinical studies of [11C]-thymidine and other PET-labeled thymidine analogues set the stage for early clinical studies that provided very promising
Acknowledgments
The authors acknowledge John R. Grierson, Janet F. Eary, and Alexander M. Spence for illustrations, patient examples, and helpful discussions; and Mark Muzi and Jeanne M. Link for collaborations and helpful discussions regarding data analysis and metabolite analysis methods.
References (85)
- et al.
PET imaging of cancer: FDG and beyond
Semin Radiol Oncol
(2001) - et al.
Selective alkylation of pyrimidyldianions: synthesis and purification of 11C labeled thymidine for tumor visualization using positron emission tomography
Int J Appl Radiat Isot
(1984) - et al.
Production of [2-11C]thymidine for quantification of cellular proliferation with PET
Int J Rad Appl Instrum [A]
(1991) - et al.
Synthesis of 11C-labelled thymidine for tumor visualization using positron emission tomography
Int J Rad Appl Instrum [A]
(1989) - et al.
Development of labeled thymidine analogs for imaging tumor proliferation
Nucl Med Biol
(1996) - et al.
Nucleoside transport in normal and neoplastic cells
Adv Enzyme Regul
(1993) - et al.
Thymidine transport in cultured mammalian cells. Kinetic analysis, temperature dependence and specificity of the transport system
Biochim Biophys Acta
(1979) - et al.
Regulation of human thymidine kinase during the cell cycle
J Biol Chem
(1988) - et al.
Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency
Biochem Biophys Res Commun
(2003) - et al.
Synthesis of 6-methyl[11C]-2′-deoxyuridine and evaluation of its in vivo distribution in Wistar rats
Nucl Med Biol
(1997)
Radiosynthesis and quality assurance of 5-[124I]-Iodo-2′-deoxyuridine for functional PET imaging of cell proliferation
Nucl Med Biol
[76Br]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice
Nucl Med Biol
Radiosynthesis of 3′-deoxy-3′-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo
Nucl Med Biol
Kinetics of 3′-deoxy-3′-[F-18]fluorothymidine uptake and retention in dogs
Mol Imaging Biol
Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines
Nucl Med Biol
Imaging [(18)F]FAU [1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl) uracil] in dogs
Nucl Med Biol
Synthesis of 2′-fluoro-5-[11C]-methyl-1-beta-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET
Nucl Med Biol
Synthesis of 2′-[18F]fluoro-2′-deoxy-β-D-arabinofuranosyl nucleotides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential pet agents for imaging cellular proliferation
Nucl Med Biol
Pharmacokinetics of the thymidine analog 2′-fluoro-5-[(14)C]-methyl-1- beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells
Nucl Med Biol
Independent blood-brain barrier transport systems for nucleic acid precursors
Biochim Biophys Acta
Cell proliferation
Thymidine metabolism and cell kinetics
Front Biol
In vitro determination of thymidine-[H-3] labeling index in human solid tumors
Cancer Res
The clinical applications of cell kinetics in cancer therapy
Ann Rev Toxicol
Detection of DNA synthesis in intact organisms with positron-emitting methyl-[C-11]-thymidine
Proc Natl Acad Sci U S A
Alternatives in the synthesis of 2-[C-11]-thymidine
J Label Comp Radiopharm
Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis
J Nucl Med
Imaging cellular proliferation as a measure of response to therapy
J Clin Pharmacol
PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls
J Nucl Med
Short-term thymidine uptake in normal and neoplastic tissues: studies for PET
J Nucl Med
Thymidine transport by cultured Novikoff hepatoma cells and uptake by simple diffusion and relationship to incorporation into deoxyribonucleic acid
J Cell Biol
A model for compartmentation of de novo and salvage thymidine nucleotide pools in mammalian cells
Proc Natl Acad Sci U S A
Cellular sources of thymidine nucleotides: studies for PET
J Nucl Med
Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase
Cancer Res
[Methyl-carbon-11] thymidine for in vivo measurement of cell proliferation
J Nucl Med
Measurement of [methyl-carbon-11]thymidine and its metabolites in head and neck tumors
J Nucl Med
Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging
J Nucl Med
Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds
J Nucl Med
A general method to correct PET data for tissue metabolites using a dual-scan approach
J Nucl Med
Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis
Mol Imaging
Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies
J Nucl Med
Carbon-11-thymidine and FDG to measure therapy response
J Nucl Med
Cited by (0)
Supported by NIH Grants P01 CA42045, R01 CA72064, RO1 CA39566, K24 CA82645, and RO1 CA83131.